Polymeric carriers for immunohistochemistry and in situ hybridization

Patent metadata

Field	Value
Publication number	US-9575067-B2
Application number	US-201514789077-A
Country	US
Kind code	B2
Filing date	Jul 1, 2015
Priority date	May 23, 2007
Publication date	Feb 21, 2017
Grant date	Feb 21, 2017

Abstract

Certain disclosed embodiments of the present invention concern the synthesis, derivatization, conjugation to immunoglobulins and signal amplification based on discrete, relatively short polymers having plural reactive functional groups that react with plural molecules of interest. Reactive functional groups, such as hydrazides, may be derivatized with a variety of detectable labels, particularly haptens. The remaining reactive functional groups may be conjugated directly to a specific binding molecule, such as to the oxidized carbohydrate of the Fc region of the antibody. Disclosed conjugates display large signal amplification as compared to those based on molecules derivatized with single haptens, and are useful for assay methods, particularly multiplexed assays.

First claim

We claim:

1. A conjugate comprising a specific binding moiety, a polymeric carrier, and at least one detectable label, the polymeric carrier having a polymeric portion comprising at least one type of repeating monomeric unit, the polymeric portion further comprising a plurality of reactive functional groups, wherein the specific binding entity is coupled to the polymeric carrier through at least one of the plurality of reactive functional groups, and wherein the at least one detectable label is indirectly coupled to the polymeric carrier through at least another of the plurality of reactive functional groups, wherein the indirect coupling of the at least one detectable label is through a linker.

2. The conjugate of claim 1 , wherein the linker is an aliphatic chain comprising between 1 and 30 carbon atoms, wherein the aliphatic chain may be saturated or unsaturated.

3. The conjugate of claim 1 , wherein the linker has the formula (—OCH 2 CH 2 O—) n , where n ranges from 2 to 25.

4. The conjugate of claim 1 , wherein the at least one type of repeating monomeric unit is derived from a polyacrylic acid, a polyacrylamide-N-hydroxysuccinimide, a polyethyleneimine, a polysaccharide, a polyethylene-alt-maleic acid, a polyamino acid, and a polyvinylpyrrolidone.

5. The conjugate of claim 1 , wherein the polymeric carrier is a polyacrylamide hydrazide having a molecular weight of between 10,000 g/mol and 20,000 g/mol.

6. The conjugate of claim 1 , wherein the polymeric carrier is a polyacrylamide hydrazide having a molecular weight of less than 10,000 g/mol.

7. The conjugate of claim 1 , where the polymeric carrier has an aqueous solubility of at least 5 mg/mL.

8. The conjugate of claim 1 , where the at least one detectable label is a hapten selected from the group consisting of oxazoles, pyrazoles, thiazoles, benzofurazans, triterpenes, ureas, thioureas, nitroaryls other than dinitrophenyl, rotenoids, coumarins, cyclolignans, heterobiaryls, azoaryls, benzodiazepines, and combinations thereof.

9. The conjugate according to claim 1 , where the at least one detectable label is selected from the group consisting of an enzyme, a fluorophore, a luminophore, a hapten, a fluorescent nanoparticle, and combinations thereof.

10. The conjugate according to claim 1 , where the specific binding molecule is Avidin, an antibody, a nucleic acid, a peptide nucleic acid (PNA), or an aptamer.

11. A conjugate comprising a specific binding moiety, a polymeric carrier, and plural haptens, the polymeric carrier having a polymeric portion comprising at least one type of repeating monomeric unit, the polymeric portion further comprising a plurality of reactive functional groups, wherein the specific binding entity is coupled to the polymeric carrier through at least one of the plurality of reactive functional groups, and wherein the plural haptens are each directly or indirectly coupled to the polymeric carrier through another of the plurality of reactive functional groups.

12. The conjugate of claim 11 , wherein the indirect coupling of the plural haptens is through a linker.

13. The conjugate of claim 12 , wherein the linker is an aliphatic chain comprising between 1 and 30 carbon atoms, wherein the aliphatic chain may be saturated or unsaturated.

14. The conjugate of claim 12 , wherein the linker has the formula (—OCH 2 CH 2 O—) n , where n ranges from 2 to 25.

15. The conjugate of claim 11 , wherein the at least one type of repeating monomeric unit is derived from a polyacrylic acid, a polyacrylamide-N-hydroxysuccinimide, a polyethyleneimine, a polysaccharide, a polyethylene-alt-maleic acid, a polyamino acid, and a polyvinylpyrrolidone.

16. The conjugate of claim 11 , wherein the plurality of reactive functional groups are selected from the group consisting of hydrazines, hydrazides, hydrazine derivatives, hydrazide derivatives, guanidines, aminoguanidines, hydroxyl amines, and combinations thereof.

17. The conjugate of claim 11 , wherein the plural haptens are selected from from the group consisting of oxazoles, pyrazoles, thiazoles, benzofurazans, triterpenes, ureas, thioureas, nitroaryls other than dinitrophenyl, rotenoids, coumarins, cyclolignans, heterobiaryls, azoaryls, benzodiazepines, and combinations thereof.

18. The conjugate of claim 11 , wherein the plural haptens are selected from the group consisting of di-nitrophenyl, biotin, digoxigenin, fluorescein, rhodamine, and combinations thereof.

19. A conjugate comprising an antibody, a polymeric carrier, and at least one hapten, the polymeric carrier having a polymeric portion comprising at least one type of repeating monomeric unit, the polymeric portion further comprising a plurality of reactive functional groups, wherein an oxidized Fc portion of the antibody is directly coupled to one of the plurality of reactive functional groups of the polymeric carrier, and wherein the at least one hapten is coupled directly or indirectly to the polymeric carrier through at least another of the plurality of reactive functional groups.

20. The conjugate of claim 19 , wherein the plurality of reactive functional groups are selected from the group consisting of hydrazines, hydrazides, hydrazine derivatives, hydrazide derivatives, guanidines, aminoguanidines, hydroxyl amines, and combinations thereof.

Assignees

• Ventana Med Syst Inc

Inventors

• Kosmeder Ii Jerry W
• Kernag Casey A
• Johnson Donald
• Bieniarz Christopher

Classifications

• G01N33/5759

  involving compounds localised on the membrane of tumour or cancer cells · CPC title

• G01N33/54353

  with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393) · CPC title

• A61K49/0067

  quantum dots, fluorescent nanocrystals · CPC title

• A61K47/6883

  Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy · CPC title

• G01N33/588

  with semiconductor nanocrystal label, e.g. quantum dots · CPC title